Literature DB >> 9699761

A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy.

D A Wing1, C M Hendershott, L Debuque, L K Millar.   

Abstract

OBJECTIVE: To compare the effectiveness of three antibiotic regimens for the treatment of acute pyelonephritis in pregnancy.
METHODS: One hundred seventy-nine pregnant women earlier than 24 weeks' gestation who had acute pyelonephritis were randomized to 1) intravenous (i.v.) ampicillin and gentamicin, 2) i.v. cefazolin, or 3) intramuscular ceftriaxone. All participants then completed 10-day courses of oral cephalexin after primary treatment. A urine culture was performed on admission and 5-14 days after completion of therapy. Surveillance for persistent or recurrent infection and obstetric complications continued until delivery. On the basis of a two-sided hypothesis test and with alpha = .025, 60 subjects were needed in each group for statistical power greater than 80% to detect a difference between ceftriaxone and other antibiotics if hospital length of stay differed by 1 or more days.
RESULTS: The treatment groups were similar in age, parity, temperature, gestational age, and initial white blood cell count. There were no statistically significant differences in length of hospitalization, hours until becoming afebrile, days until resolution of costovertebral angle tenderness, or infecting organism. There were no statistically significant differences in birth outcomes between the three groups. The average (standard deviation) age at delivery was 38.8 +/- 3.6 weeks. The average birth weight was 3274 +/- 523 g. Eleven (6.9%) of 159 subjects delivered prematurely. Escherichia coli was the most common uropathogen isolated (137 of 179, 76.5%). Blood cultures were positive for organisms in 15 cases (8.4%). At follow-up examination within 2 weeks of initial therapy, eight (5.0%) of 159 subjects had urine cultures positive for organisms. Ten women (6.3%) had cultures positive for organisms later in their antepartum course, and 10 other participants (6.3%) developed recurrent pyelonephritis.
CONCLUSION: There are no significant differences in clinical response to antimicrobial therapy or birth outcomes among subjects treated with ampicillin and gentamicin, cefazolin, or ceftriaxone for acute pyelonephritis in pregnancy before 24 weeks' gestation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699761     DOI: 10.1016/s0029-7844(98)00156-2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

Review 1.  Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.

Authors:  Jennifer A Jolley; Deborah A Wing
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

Review 2.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

Review 4.  Treatments for symptomatic urinary tract infections during pregnancy.

Authors:  Juan C Vazquez; Edgardo Abalos
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 5.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.

Authors:  Mical Paul; Ishay Benuri-Silbiger; Karla Soares-Weiser; Leonard Leibovici
Journal:  BMJ       Date:  2004-03-02

6.  Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.

Authors:  Rose McGready; Vanaporn Wuthiekanun; Elizabeth A Ashley; Saw Oo Tan; Mupawjay Pimanpanarak; Samuel Jacher Viladpai-Nguen; Wilarat Jesadapanpong; Stuart D Blacksell; Stephane Proux; Nicholas P Day; Pratap Singhasivanon; Nicholas J White; François Nosten; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

7.  Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.

Authors:  H Malekinejad; A Nikibakhsh; S Gholizadeh-Soltani; A Farshid
Journal:  Indian J Nephrol       Date:  2012-01

8.  Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters.

Authors:  Chih-Chia Hsieh; Po-Lin Chen; Chung-Hsun Lee; Chao-Yung Yang; Ching-Chi Lee; Wen-Chien Ko
Journal:  J Clin Med       Date:  2020-01-07       Impact factor: 4.241

Review 9.  Sepsis in Pregnancy: Recognition and Resuscitation.

Authors:  Rachel E Bridwell; Brandon M Carius; Brit Long; Joshua J Oliver; Gillian Schmitz
Journal:  West J Emerg Med       Date:  2019-08-06

10.  Pyelonephritis in Pregnancy From the Lens of an Underserved Community.

Authors:  Chioma C Umeh; Okelue E Okobi; Olamide I Olawoye; Chukwuebuka Agu; Jovita Koko; Joseph Okoeguale
Journal:  Cureus       Date:  2022-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.